4//SEC Filing
Thompson Rahsaan 4
Accession 0001209191-22-053457
CIK 0001806952other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 4:10 PM ET
Size
5.4 KB
Accession
0001209191-22-053457
Insider Transaction Report
Form 4
Thompson Rahsaan
Chief Legal Officer
Transactions
- Award
Option (right to buy)
2022-10-10+715,000→ 715,000 totalExercise: $6.91Exp: 2032-10-09→ Common Stock (715,000 underlying)
Footnotes (1)
- [F1]1/4 of the option shares shall vest on September 28, 2023, with the remaining option shares to vest in equal monthly installments over the following thirty-six months.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001788524
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 4:10 PM ET
- Size
- 5.4 KB